The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts say.

NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...

Everything you need to know about agonising sickle cell disease and the ‘revolutionary’ new DNA therapy that's being rolled ...

SaveHealth explores the potential prescription cost savings that can be achieved by leveraging cash prices and discount cards, providing insights based on real-world drug pricing data.

We've tested many a comfortable mattress when putting together our best mattress of 2025 guide, but the best smart beds like ...

EyePoint's Duravyu, a potential "best-in-class" therapy for Wet AMD and DME, could disrupt the market with fewer injections ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, today we look at ...

It was about a year ago that shares of Iovance Biotherapeutics (NASDAQ: IOVA) began to take off. Could this be a great buying ...

Victor Wembanyama said his charge at Ivica Zubac during a San Antonio Spurs loss to the Los Angeles Clippers was the result of building frustration from what he believes is unfair treatment by NBA ...

We recently compiled a list of the Jim Cramer Discussed These 11 Stocks Before The DeepSeek Sell-Off. In this article, we are going to take a look at where Advanced Micro Devices, Inc.

Chocolate lovers may need to dig deeper into their pockets as the price of their favourite sweet treat is set to rise. With cocoa prices reaching record highs, manufacturers are passing the cost onto ...

We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...